BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17494859)

  • 1. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML.
    Heuser M; Argiropoulos B; Kuchenbauer F; Yung E; Piper J; Fung S; Schlenk RF; Dohner K; Hinrichsen T; Rudolph C; Schambach A; Baum C; Schlegelberger B; Dohner H; Ganser A; Humphries RK
    Blood; 2007 Sep; 110(5):1639-47. PubMed ID: 17494859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.
    Heuser M; Beutel G; Krauter J; Döhner K; von Neuhoff N; Schlegelberger B; Ganser A
    Blood; 2006 Dec; 108(12):3898-905. PubMed ID: 16912223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation.
    Seipel K; Messerli C; Wiedemann G; Bacher U; Pabst T
    Leuk Res; 2020 Feb; 89():106296. PubMed ID: 31927137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.
    Schwind S; Marcucci G; Kohlschmidt J; Radmacher MD; Mrózek K; Maharry K; Becker H; Metzeler KH; Whitman SP; Wu YZ; Powell BL; Baer MR; Kolitz JE; Carroll AJ; Larson RA; Caligiuri MA; Bloomfield CD
    Blood; 2011 Oct; 118(15):4188-98. PubMed ID: 21828125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcriptional corepressor CBFA2T3 inhibits all-
    Steinauer N; Guo C; Zhang J
    J Biol Chem; 2020 Jul; 295(27):8887-8900. PubMed ID: 32434928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningioma 1 (MN1) expression: refined risk stratification in acute myeloid leukemia with normal cytogenetics (CN-AML).
    Aref S; Ibrahim L; Morkes H; Azmy E; Ebrahim M
    Hematology; 2013 Sep; 18(5):277-83. PubMed ID: 23394438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of MN1 sequences necessary for myeloid transformation.
    Kandilci A; Surtel J; Janke L; Neale G; Terranova S; Grosveld GC
    PLoS One; 2013; 8(4):e61706. PubMed ID: 23626719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MN1 affects expression of genes involved in hematopoiesis and can enhance as well as inhibit RAR/RXR-induced gene expression.
    Meester-Smoor MA; Janssen MJ; Grosveld GC; de Klein A; van IJcken WF; Douben H; Zwarthoff EC
    Carcinogenesis; 2008 Oct; 29(10):2025-34. PubMed ID: 18632758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.
    Kawagoe H; Grosveld GC
    Blood; 2005 Dec; 106(13):4269-77. PubMed ID: 16105979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
    Mueller BU; Pabst T; Fos J; Petkovic V; Fey MF; Asou N; Buergi U; Tenen DG
    Blood; 2006 Apr; 107(8):3330-8. PubMed ID: 16352814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of MN1 confers resistance to chemotherapy, accelerates leukemia onset, and suppresses p53 and Bim induction.
    Pardee TS
    PLoS One; 2012; 7(8):e43185. PubMed ID: 22905229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML.
    Jentzsch M; Bill M; Grimm J; Brauer D; Backhaus D; Goldmann K; Schulz J; Niederwieser D; Platzbecker U; Schwind S
    Ann Hematol; 2020 Oct; 99(10):2417-2427. PubMed ID: 32862286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salt-inducible kinase inhibition sensitizes human acute myeloid leukemia cells to all-trans retinoic acid-induced differentiation.
    Zhang XW; Shen X; Long WY; Xiao H; Li FJ; Xing S; Xiong GL; Yu ZY; Cong YW
    Int J Hematol; 2021 Feb; 113(2):254-262. PubMed ID: 33074481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable but consistent pattern of Meningioma 1 gene (MN1) expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detection.
    Carturan S; Petiti J; Rosso V; Calabrese C; Signorino E; Bot-Sartor G; Nicoli P; Gallo D; Bracco E; Morotti A; Panuzzo C; Gottardi E; Frassoni F; Saglio G; Cilloni D
    Oncotarget; 2016 Nov; 7(45):74082-74096. PubMed ID: 27765915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells.
    Liu L; Liu L; Leung LH; Cooney AJ; Chen C; Rosengart TK; Ma Y; Yang J
    J Biol Chem; 2015 Apr; 290(17):10599-609. PubMed ID: 25737450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment.
    Su M; Alonso S; Jones JW; Yu J; Kane MA; Jones RJ; Ghiaur G
    PLoS One; 2015; 10(6):e0127790. PubMed ID: 26047326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.
    Nishioka C; Ikezoe T; Yang J; Gery S; Koeffler HP; Yokoyama A
    Int J Cancer; 2009 Oct; 125(7):1710-20. PubMed ID: 19507250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.
    Tokura Y; Shikami M; Miwa H; Watarai M; Sugamura K; Wakabayashi M; Satoh A; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
    Leuk Res; 2002 Jan; 26(1):29-36. PubMed ID: 11734301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML.
    Riedel SS; Lu C; Xie HM; Nestler K; Vermunt MW; Lenard A; Bennett L; Speck NA; Hanamura I; Lessard JA; Blobel GA; Garcia BA; Bernt KM
    Mol Cell; 2021 Jun; 81(11):2332-2348.e9. PubMed ID: 33974912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice.
    Lin CC; Yao CY; Hsu YC; Hou HA; Yuan CT; Li YH; Kao CJ; Chuang PH; Chiu YC; Chen Y; Chou WC; Tien HF
    Oncogene; 2020 Jul; 39(28):5112-5123. PubMed ID: 32533098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.